Lenalidomide results in a durable complete remission in acute myeloid leukemia accompanied by persistence of somatic mutations and a T-cell infiltrate in the bone marrow

Research paper by Bansal, D, Vij, K, Chang, G. S, Miller, C. A, DiPersio, J. F, Vij, R, Heath, S. E, Westervelt, et al.

Indexed on: 10 Jun '18Published on: 04 Jun '18Published in: Haematologica

Read article More Like This

Abstract

Authors: Bansal, D ; Vij ; K ; Chang ; G. S ; Miller ; C. A ; DiPersio ; J. F ; Vij ; R ; Heath ; S. E ; Westervelt ; P ; Welch ; J. S ; Fehniger ; T. A. Article URL: http://www.haematologica.org/cgi/reprint/103/6/e270?rss=1 Citation: Vol 103 No. 6 (2018) pp e270 e273 Publication Date: 2018-06-03T23:55:04-07:00 Journal: Haematologica - the Hematology journal

Lenalidomide results in a durable complete remission in acute myeloid leukemia accompanied by persistence of somatic mutations and a T-cell infiltrate in the bone marrow

Abstract

More like this:

Shortened telomeres in essential thrombocythemia: clinicopathological and treatment correlations

Survival adjusting for crossover: phase 3 study of ibrutinib vs. chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphoma

Down syndrome-like acute megakaryoblastic leukemia in a patient with Cornelia de Lange syndrome

Lenalidomide results in a durable complete remission in acute myeloid leukemia accompanied by persistence of somatic mutations and a T-cell infiltrate in the bone marrow

Abstract

More like this:

Shortened telomeres in essential thrombocythemia: clinicopathological and treatment correlations

Survival adjusting for crossover: phase 3 study of ibrutinib vs. chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphoma

Down syndrome-like acute megakaryoblastic leukemia in a patient with Cornelia de Lange syndrome

This website uses cookies